- INDEGENE LIMITED
67% Hold
INDEGENE LIMITED Share Price
INDGN
INDEGENE LIMITED Share Price Chart
Company overview
INDEGENE LIMITED Financials
Market cap  ₹14,994 Crs | Open ₹625.00 | Close ₹626.65 |
Circuit range ₹763.70 - ₹509.20 | Day range ₹624.25 - ₹639.70 | Year range ₹470.10 - ₹736.30 |
Volume 1,03,961 | Avg. traded ₹635.68 | Revenue (12m) ₹0 Crs |
INDEGENE LIMITED Key indicators
52 week high ₹736.30 | 52 week low ₹470.10 | P/E ratio 46.37 |
P/B ratio 6.61 | ROE 16.22% | ROCE 21.41% |
Dividend yield -- | Debt/Equity ratio | EPS 6.21 |
Learn more
Featured in
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Hold
Analyst ratings:
Hold0%
Hold
67%
Sell
33%
This analysis is based on the reviews of 3 experts in the last 7 days
INDEGENE LIMITED Fundamentals
INDEGENE LIMITED Financial Ratios
Operating profit margin20.88% | Net profit margin13.19% |
ROE16.22% | ROA12.37% |
ROCE21.41% |
Learn more
INDEGENE LIMITED Shareholder returns
1 day | 1 week -5.77% | 1 month -13.14% |
3 months | 1 year | 3 years |
5 years |
INDEGENE LIMITED Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Fri, Nov 1 2024 | ₹625.00 | ₹636.45 | |
Thu, Oct 31 2024 | ₹621.60 | ₹626.65 | |
Wed, Oct 30 2024 | ₹652.05 | ₹621.60 | -4.75% |
Tue, Oct 29 2024 | ₹691.00 | ₹652.60 | -5.50% |
Mon, Oct 28 2024 | ₹675.00 | ₹690.55 | |
Fri, Oct 25 2024 | ₹688.50 | ₹675.45 | -1.11% |
Thu, Oct 24 2024 | ₹675.60 | ₹683.05 | |
Wed, Oct 23 2024 | ₹657.00 | ₹674.20 |
INDEGENE LIMITED Shareholding Pattern
Promoters (0%) | Mutual Funds (1.64%) | Retail and other (92.01%) |
Foreign institutions-FII (4.82%) | Other domestic institutions (1.53%) |
Learn more
People also bought
INDEGENE LIMITED News
CNBC
Indegene shares may not see much upside, according to Nomura
Livemint
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Sept 23
Livemint
Down 15% from debut, JPMorgan neutral on Indegene
CNBC
Indegene shares are 'fairly priced': JPMorgan on new launch uncertainty
Moneycontrol
Indegene partners Microsoft to scale up GenAI adoption; stock gains 3%
ET
Hot stocks: Brokerage take on L&T Finance, Bajaj Finance, Indegene
CNBC
Citi says Indegene valuation captures positives, expects 7% downside
CNBC
Indegene gains on partnership with Ignite Life Science Foundation and IISc
Upstox
May 2024 IPO review: Stellar returns from TBO Tek, Indegene, and more
Livemint
Indegene share price tanks 12% after bumper debut. Buy, sell or hold?